António Medina de Almeida, director of the Hematology service of Hospital da Luz Lisboa and university professor, will give, this month, two educational lectures on chronic myeloid leukemia. The first intervention will occur in HEMO 2019 congress – the major meeting of the specialty in Latin America, which is taking place in Rio de Janeiro, between 6 and 9 November – and the second one in the annual meeting of the Portuguese Society of Hematology , between 14 and 16 November, in Braga. Chronic myeloid leukemia is a rare type of blood cancer that, in Portugal, affects one to two persons in a hundred thousand, a year, being one of the preferential areas of research in António Medina de Almeida’s work. The Hospital da Luz Lisboa specialist is, since June 2018, member of the board of the European Hematology Association (EHA) and president of the curricular and educational committee of this organization, being, in that context, responsible for defining the European curriculum of Hematology for European medical schools and the annual European exam for the specialty. He is also responsible for myeloid pathologies in the scientific working group of the EHA annual congress, which will take place in June 2020, in Germany.
